Evidence map›Paper›PMID 22511919›Full record

ArticlePloS one2012

Xer recombinase and genome integrity in Helicobacter pylori, a pathogen without topoisomerase IV.

Aleksandra W Debowski, Christophe Carnoy, Phebe Verbrugghe, Hans-Olof Nilsson, Jonathan C Gauntlett, Alma Fulurija, Tania Camilleri, Douglas E Berg, Barry J Marshall, Mohammed Benghezal

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. RecombinantAntibiotics (Basel, Switzerland) · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Aleksandra W DebowskiOndek Pty Ltd and Helicobacter pylori Research Laboratory, School of Pathology & Laboratory Medicine, M504, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands, Western Australia.
Christophe Carnoy
Phebe Verbrugghe
Hans-Olof Nilsson
Jonathan C Gauntlett
Alma Fulurija
Tania Camilleri
Douglas E Berg
Barry J Marshall
Mohammed Benghezal
University of Western Australia · AUCentre National de la Recherche Scientifique · FRWashington University in St. Louis · US

Funding

NOVEL TRANSPOSONS AND PLASTICITY ZONES OF HELICOBACTER PYLORIR21AI088337 · NIAID · WASHINGTON UNIVERSITY · PI BERG, DOUGLAS EUGENE · 2010 to 2011
$416k
HELICOBACTER PYLORI GENOME SEQUENCE EVOLUTIONR21AI078237 · NIAID · WASHINGTON UNIVERSITY · PI BERG, DOUGLAS EUGENE · 2009 to 2010
$266k
NIAID NIH HHS R21 AI078237NIAID NIH HHS R21 AI088337
6 · The paper itself

Abstract

In the model organism E. coli, recombination mediated by the related XerC and XerD recombinases complexed with the FtsK translocase at specialized dif sites, resolves dimeric chromosomes into free monomers to allow efficient chromosome segregation at cell division. Computational genome analysis of Helicobacter pylori, a slow growing gastric pathogen, identified just one chromosomal xer gene (xerH) and its cognate dif site (difH). Here we show that recombination between directly repeated difH sites requires XerH, FtsK but not XerT, the TnPZ transposon associated recombinase. xerH inactivation was not lethal, but resulted in increased DNA per cell, suggesting defective chromosome segregation. The xerH mutant also failed to colonize mice, and was more susceptible to UV and ciprofloxacin, which induce DNA breakage, and thereby recombination and chromosome dimer formation. xerH inactivation and overexpression each led to a DNA segregation defect, suggesting a role for Xer recombination in regulation of replication. In addition to chromosome dimer resolution and based on the absence of genes for topoisomerase IV (parC, parE) in H. pylori, we speculate that XerH may contribute to chromosome decatenation, although possible involvement of H. pylori's DNA gyrase and topoisomerase III homologue are also considered. Further analyses of this system should contribute to general understanding of and possibly therapy development for H. pylori, which causes peptic ulcers and gastric cancer; for the closely related, diarrheagenic Campylobacter species; and for unrelated slow growing pathogens that lack topoisomerase IV, such as Mycobacterium tuberculosis.

Indexed as

Bacterial ProteinsChromosome SegregationCiprofloxacinDNA Topoisomerase IVHelicobacter pyloriMicrobial Sensitivity TestsMutagenesis, Site-DirectedPoint MutationRecombinasesRecombination, GeneticBacterial ProteinsCiprofloxacinDNA Topoisomerase IVRecombinases

Identifiers

PMID22511919
PMCPMC3325230
OpenAlexW2050049120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.